Publications (26)
Immunai’s team has published groundbreaking work in a variety of top-tier journals. Immunai is committed to continuing to innovate and push the boundaries of immunology, machine learning and single cell genomic technologies via scholarly publications and collaborations with leading academic partners.
Publications
12/11/2025
Macrophage-targeted immunocytokine leverages myeloid, T, and NK cell synergy for cancer immunotherapy
Publications
11/05/2025
Long-term Remission After Cilta-Cel in Multiple Myeloma Is Linked to Diverse T Cells and Low Myeloid Suppression
Publications
07/07/2024
Single cell view of tumor microenvironment gradients in pleural mesothelioma
Publications
02/28/2024
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells
Publications
02/20/2024
Immunomodulatory effects and improved outcomes with cisplatin- versus carboplatin-based chemotherapy plus atezolizumab in urothelial cancer
Publications
01/12/2024
Disruption of SUV39H1-Mediated H3K9 Methylation Sustains CAR T-cell Function
Publications
10/22/2023
1883MO – MEDI5752 (volrustomig), a novel PD-1/CTLA-4 bispecific antibody, in the first-line (1L) treatment of 65 patients (pts) with advanced clear cell renal cell carcinoma (aRCC)
Publications
08/01/2023